Keith Lamont Cummings - May 2, 2024 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Financial Officer
Signature
/s/ Mike Ouimette, attorney-in-fact
Stock symbol
PLRX
Transactions as of
May 2, 2024
Transactions value $
$43,680
Form type
4
Date filed
5/6/2024, 06:02 AM
Previous filing
Jan 24, 2024
Next filing
Jul 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Options Exercise $43.7K +21K +8.38% $2.08 272K May 2, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (Right to Buy) Options Exercise $0 -21K -21.64% $0.00 76K May 2, 2024 Common Stock 21K $2.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 858 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
F2 25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vested in substantially equal monthly installments thereafter, all of which were subject to the Reporting Person's continuous service to the Issuer on each such date.